After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...
Wed, 02 Apr 2014 14:22:53 GMT — The doctor treating Hall of Fame quarterback Jim Kelly for cancer says Kelly will start chemotherapy and radiation next week. The treatment plan was outlined Tuesday by ...
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback